Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma
Status:
Completed
Trial end date:
2011-05-17
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to document the progression free survival (PFS) in
advanced or metastatic small cell lung carcinoma (SCLC) patients previously treated with at
least one therapeutic regimen